Next Article in Journal
Expression of Stipa purpurea SpCIPK26 in Arabidopsis thaliana Enhances Salt and Drought Tolerance and Regulates Abscisic Acid Signaling
Next Article in Special Issue
Leptin Receptor Metabolism Disorder in Primary Chondrocytes from Adolescent Idiopathic Scoliosis Girls
Previous Article in Journal
Selection of Suitable Reference Genes for Quantitative Real-Time PCR Normalization in Three Types of Rat Adipose Tissue
Previous Article in Special Issue
The Autophagic Process Occurs in Human Bone Metastasis and Implicates Molecular Mechanisms Differently Affected by Rab5a in the Early and Late Stages
Review

Bone Metastasis from Renal Cell Carcinoma

by 1,2,3,4 and 1,5,*
1
Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
2
Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan
3
Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung 812, Taiwan
4
Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
5
Institute of Medical Science and Technology, National Sun Yat-Sen University, Kaohsiung 804, Taiwan
*
Author to whom correspondence should be addressed.
Academic Editor: Maria Alfonsina Desiderio
Int. J. Mol. Sci. 2016, 17(6), 987; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17060987
Received: 22 May 2016 / Revised: 17 June 2016 / Accepted: 18 June 2016 / Published: 22 June 2016
(This article belongs to the Special Issue Cellular and Molecular Mechanisms of Bone Metastasis)
About one-third of patients with advanced renal cell carcinoma (RCC) have bone metastasis that are often osteolytic and cause substantial morbidity, such as pain, pathologic fracture, spinal cord compression and hypercalcemia. The presence of bone metastasis in RCC is also associated with poor prognosis. Bone-targeted treatment using bisphosphonate and denosumab can reduce skeletal complications in RCC, but does not cure the disease or improve survival. Elucidating the molecular mechanisms of tumor-induced changes in the bone microenvironment is needed to develop effective treatment. The “vicious cycle” hypothesis has been used to describe how tumor cells interact with the bone microenvironment to drive bone destruction and tumor growth. Tumor cells secrete factors like parathyroid hormone-related peptide, transforming growth factor-β and vascular endothelial growth factor, which stimulate osteoblasts and increase the production of the receptor activator of nuclear factor κB ligand (RANKL). In turn, the overexpression of RANKL leads to increased osteoclast formation, activation and survival, thereby enhancing bone resorption. This review presents a general survey on bone metastasis in RCC by natural history, interaction among the immune system, bone and tumor, molecular mechanisms, bone turnover markers, therapies and healthcare burden. View Full-Text
Keywords: renal cell carcinoma; bone metastasis; molecular mechanisms; bone turnover markers; therapies renal cell carcinoma; bone metastasis; molecular mechanisms; bone turnover markers; therapies
Show Figures

Figure 1

MDPI and ACS Style

Chen, S.-C.; Kuo, P.-L. Bone Metastasis from Renal Cell Carcinoma. Int. J. Mol. Sci. 2016, 17, 987. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17060987

AMA Style

Chen S-C, Kuo P-L. Bone Metastasis from Renal Cell Carcinoma. International Journal of Molecular Sciences. 2016; 17(6):987. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17060987

Chicago/Turabian Style

Chen, Szu-Chia, and Po-Lin Kuo. 2016. "Bone Metastasis from Renal Cell Carcinoma" International Journal of Molecular Sciences 17, no. 6: 987. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17060987

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop